Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients (CTNG)

This study has been completed.

Sponsor:

Collaborators:

Pfizer

Merck Sharp & Dohme Corp.

Information provided by:

University Hospital Inselspital, Berne

ClinicalTrials.gov Identifier:

NCT00973466

First received: September 4, 2009

Last updated: January 12, 2011

Last verified: January 2011

History of Changes

Purpose

There has been an increase in incidence in sexually transmitted infections in HIV infected patients in the last years. In this study the investigators will prospectively evaluate the prevalence of symptomatic and asymptomatic infections with N. gonorrhea and Ch. trachomatis as well as the seroprevalence of Herpes simplex Type 2 infection in HIV-infected patients attending the clinic for infectious diseases at the Berne University Hospital. In addition, participants will be asked to fill out a questionnaire on sexual behaviour and sexual health.

Study hypothesis: STI prevalence is high in certain risk-groups to justify screening in regular intervals.

Condition
HIV Infections Neisseria Gonorrhoeae Chlamydia Trachomatis Herpes Simplex


Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	Prevalence of Asymptomatic and Symptomatic Infection of N. Gonorrheae and C. Trachomatis and Seroprevalence of HSV Typ 2 and Sexual Health Seeking Behaviour in People With HIV Infection in Bern

Resource links provided by NLM:

MedlinePlus related topics: Chlamydia Infections Gonorrhea HIV/AIDS Herpes Simplex Sexually Transmitted Diseases

U.S. FDA Resources

Further study details as provided by University Hospital Inselspital, Berne:

Primary Outcome Measures:

Prevalence of infection with C.trachomatis, N. gonorrhea and Seroprevalence of HSV 2 infection [ Time Frame: 6 months ] [ Designated as safety issue: No ]


Estimated Enrollment:	300
Study Start Date:	May 2009
Study Completion Date:	June 2010
Primary Completion Date:	May 2010 (Final data collection date for primary outcome measure)

Groups/Cohorts
HIV-infection All HIV-infected patients attending the Clinic for Infectious Diseases at Berne university hospital, having been sexually active during the past 12 months and having given written informed consent

Eligibility


Ages Eligible for Study:	18 Years and older (Adult, Senior)
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

All consecutive HIV-infected patients attending the Clinic for Infectious Diseases at Bern University Hospital will be asked to participate in the study if they were sexually active during the last 12 months

Criteria

Inclusion Criteria:

HIV-infection
Attending the Clinic for Infectious Diseases from May 09 to November 09
Sexually active during the last 12 months
Written informed consent

Exclusion Criteria:

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00973466

Locations


Switzerland
Clinic for Infectious Diseases, Berne University Hospital
Bern, Switzerland, 3010

Sponsors and Collaborators

University Hospital Inselspital, Berne

Pfizer

Merck Sharp & Dohme Corp.

Investigators


Principal Investigator:	Hansjakob Furrer, MD	University Hospital Berne

More Information


Responsible Party:	Hansjakob Furrer, Leitender Arzt, University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:	NCT00973466 History of Changes
Other Study ID Numbers:	KEK26/09
Study First Received:	September 4, 2009
Last Updated:	January 12, 2011
Health Authority:	Switzerland: Ethikkommission

Keywords provided by University Hospital Inselspital, Berne:


HIV-infection Neisseria gonorrhea Chlamydia trachomatis Herpes simplex virus prevalence

Additional relevant MeSH terms:


Infection Communicable Diseases HIV Infections Acquired Immunodeficiency Syndrome Herpes Simplex Chlamydia Infections Sexually Transmitted Diseases Gonorrhea Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Immunologic Deficiency Syndromes	Immune System Diseases Slow Virus Diseases Herpesviridae Infections DNA Virus Infections Skin Diseases, Viral Skin Diseases, Infectious Skin Diseases Chlamydiaceae Infections Gram-Negative Bacterial Infections Bacterial Infections Sexually Transmitted Diseases, Bacterial Genital Diseases, Male Genital Diseases, Female Neisseriaceae Infections

ClinicalTrials.gov processed this record on September 30, 2016

To Top